Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Colonic Neoplasms 5Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Motor Activity 2Gastrointestinal Neoplasms 2Vitamin D Deficiency 1Stomach Neoplasms 1Rectal Neoplasms 1Psychological Well-Being 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Osteoporosis 1Neoplasms 1Myocardial Ischemia 1Lung Neoplasms 1Inflammation 1Hypertension 1Heart Diseases 1Fibrosis 1Esophageal Neoplasms 1Coronary Disease 1Cognitive Dysfunction 1Cholangiocarcinoma 1Cardiovascular Diseases 1Breast Neoplasms 1Bone Diseases 1

Interventions

pazopanib 1Vitamin D 1Urine Specimen Collection 1Patient Navigation 1Lysine Acetyltransferase 5 1Gastrectomy 1Endoscopic Mucosal Resection 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypertension × Vitamin D × Gastrointestinal × Clear all
NCT00585637 2015-04-01

Vitamin D for Chemoprevention

Dana-Farber Cancer Institute

Phase 1 Completed
328 enrolled 11 charts
GastrointestinalGenitourinary

Gastrointestinal Neoplasms, Hypertension, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡